A Phase III, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of V114 compared with PCV13 in healthy infants (PNEU-PED-EU-1)

Federico Martinón‐Torres, Jacek Wysocki, Leszek Szenborn, Alfonso Carmona-Martinez, Airi Põder, Ron Dagan, Peter Richmond, Christopher L. Gilbert, Marie-Chantale Trudel, Sheryl Flores,

Vaccine · 2023 · 28 citations · 29 references

DOIFull text

Open access

Concepts

References

29